These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 26530156)
1. The impact of a human IGF-II analog ([Leu27]IGF-II) on fetal growth in a mouse model of fetal growth restriction. Charnock JC; Dilworth MR; Aplin JD; Sibley CP; Westwood M; Crocker IP Am J Physiol Endocrinol Metab; 2016 Jan; 310(1):E24-31. PubMed ID: 26530156 [TBL] [Abstract][Full Text] [Related]
2. Evidence of adaptation of maternofetal transport of glutamine relative to placental size in normal mice, and in those with fetal growth restriction. McIntyre KR; Hayward CE; Sibley CP; Greenwood SL; Dilworth MR J Physiol; 2019 Oct; 597(19):4975-4990. PubMed ID: 31400764 [TBL] [Abstract][Full Text] [Related]
3. eNOS knockout mouse as a model of fetal growth restriction with an impaired uterine artery function and placental transport phenotype. Kusinski LC; Stanley JL; Dilworth MR; Hirt CJ; Andersson IJ; Renshall LJ; Baker BC; Baker PN; Sibley CP; Wareing M; Glazier JD Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(1):R86-93. PubMed ID: 22552791 [TBL] [Abstract][Full Text] [Related]
4. Crossing mice deficient in eNOS with placental-specific Igf2 knockout mice: a new model of fetal growth restriction. Dilworth MR; Kusinski LC; Baker BC; Renshall LJ; Baker PN; Greenwood SL; Wareing M; Sibley CP Placenta; 2012 Dec; 33(12):1052-4. PubMed ID: 23099110 [TBL] [Abstract][Full Text] [Related]
5. Sildenafil citrate increases fetal weight in a mouse model of fetal growth restriction with a normal vascular phenotype. Dilworth MR; Andersson I; Renshall LJ; Cowley E; Baker P; Greenwood S; Sibley CP; Wareing M PLoS One; 2013; 8(10):e77748. PubMed ID: 24204949 [TBL] [Abstract][Full Text] [Related]
6. Maternal insulin-like growth factor-II promotes placental functional development via the type 2 IGF receptor in the guinea pig. Sferruzzi-Perri AN; Owens JA; Standen P; Roberts CT Placenta; 2008 Apr; 29(4):347-55. PubMed ID: 18339421 [TBL] [Abstract][Full Text] [Related]
7. Effect of sildenafil citrate treatment in the eNOS knockout mouse model of fetal growth restriction on long-term cardiometabolic outcomes in male offspring. Mills V; Plows JF; Zhao H; Oyston C; Vickers MH; Baker PN; Stanley JL Pharmacol Res; 2018 Nov; 137():122-134. PubMed ID: 30292428 [TBL] [Abstract][Full Text] [Related]
8. Effect of the anti-oxidant tempol on fetal growth in a mouse model of fetal growth restriction. Stanley JL; Andersson IJ; Hirt CJ; Moore L; Dilworth MR; Chade AR; Sibley CP; Davidge ST; Baker PN Biol Reprod; 2012 Jul; 87(1):25, 1-8. PubMed ID: 22423051 [TBL] [Abstract][Full Text] [Related]
9. Insulin-like growth factor 1 signaling in the placenta requires endothelial nitric oxide synthase to support trophoblast function and normal fetal growth. Wilson RL; Troja W; Sumser EK; Maupin A; Lampe K; Jones HN Am J Physiol Regul Integr Comp Physiol; 2021 May; 320(5):R653-R662. PubMed ID: 33621475 [TBL] [Abstract][Full Text] [Related]
12. Endothelin Receptor A Antagonism and Fetal Growth in Endothelial Nitric Oxide Synthase Gene Knockout Maternal and Fetal Mice. Luo K; Thaete LG; Neerhof MG Reprod Sci; 2016 Aug; 23(8):1028-36. PubMed ID: 26791973 [TBL] [Abstract][Full Text] [Related]
13. The role and mechanism of asymmetric dimethylarginine in fetal growth restriction via interference with endothelial function and angiogenesis. Dai Y; Zhang J; Liu R; Xu N; Yan SB; Chen Y; Li TH J Assist Reprod Genet; 2020 May; 37(5):1083-1095. PubMed ID: 32215825 [TBL] [Abstract][Full Text] [Related]
14. Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy. Cureton N; Korotkova I; Baker B; Greenwood S; Wareing M; Kotamraju VR; Teesalu T; Cellesi F; Tirelli N; Ruoslahti E; Aplin JD; Harris LK Theranostics; 2017; 7(15):3715-3731. PubMed ID: 29109771 [TBL] [Abstract][Full Text] [Related]
15. System A activity and vascular function in the placental-specific Igf2 knockout mouse. Kusinski LC; Dilworth MR; Baker PN; Sibley CP; Wareing M; Glazier JD Placenta; 2011 Nov; 32(11):871-6. PubMed ID: 21851977 [TBL] [Abstract][Full Text] [Related]
16. Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Street ME; Seghini P; Fieni S; Ziveri MA; Volta C; Martorana D; Viani I; Gramellini D; Bernasconi S Eur J Endocrinol; 2006 Oct; 155(4):567-74. PubMed ID: 16990656 [TBL] [Abstract][Full Text] [Related]
18. Maternal insulin-like growth factors-I and -II act via different pathways to promote fetal growth. Sferruzzi-Perri AN; Owens JA; Pringle KG; Robinson JS; Roberts CT Endocrinology; 2006 Jul; 147(7):3344-55. PubMed ID: 16556757 [TBL] [Abstract][Full Text] [Related]
19. Sex-Selective Increase of IGF-2 Expression in the Hypoxic Guinea Pig Placenta of Growth-Restricted Fetuses. Elsamadicy EA; Thompson LP Reprod Sci; 2022 Oct; 29(10):3015-3025. PubMed ID: 35616874 [TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical study of type I insulin-like growth factor receptors in the placentae of pregnancies with appropriately grown or growth restricted fetuses. Holmes R; Porter H; Newcomb P; Holly JM; Soothill P Placenta; 1999 May; 20(4):325-30. PubMed ID: 10329354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]